Evidence map›Paper›PMID 27312771›Full record

ArticleGenetic epidemiology2016

Post hoc Analysis for Detecting Individual Rare Variant Risk Associations Using Probit Regression Bayesian Variable Selection Methods in Case-Control Sequencing Studies.

Nicholas B Larson, Shannon McDonnell, Lisa Cannon Albright, Craig Teerlink, Janet Stanford, Elaine A Ostrander, William B Isaacs, Jianfeng Xu, Kathleen A Cooney, Ethan Lange and 22 more

Erratum issued Registry-linked trialAbstract read
In one paragraph

Article in Genetic epidemiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT01221168 (ProGene), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01221168 recruitingnot on this map

ProGene: Etude Genetique et Epidemiologique du Cancer de la Prostate Familial

TypeobservationalSponsorCentre de Recherche sur les Pathologies ProstatiquesRan1996 to 2026Enrolled10,000ConditionsProstate Cancer
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

32 authors.

Nicholas B LarsonDivision of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
Shannon McDonnellDivision of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
Lisa Cannon AlbrightDepartment of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
Craig TeerlinkDepartment of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
Janet StanfordFred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Elaine A OstranderNational Human Genome Research Institute, Bethesda, Maryland, United States of America.
William B IsaacsDepartment of Urology, Johns Hopkins Hospital, Baltimore, Maryland, United States of America.
Jianfeng XuNorthShore University HealthSystem Research Institute, Chicago, Illinois, United States of America.
Kathleen A CooneyDepartment of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.
Ethan LangeDepartment of Genetics, University of North Carolina, Chapel Hill, North Carolina, United States of America.
Johanna SchleutkerDepartment of Medical Biochemistry and Genetics, Institute of Biomedicine, University of Turku, Finland.
John D CarptenIntegrated Cancer Genomics Division, The Translational Genomics Research Institute, Phoenix, Arizona, United States of America.
Isaac PowellWayne State University, Detroit, Michigan, United States of America.
Joan Bailey-WilsonStatistical Genetics Section, National Human Genome Research Institute, Bethesda, Maryland, United States of America.
Olivier CussenotCeRePP, Hopital Tenon, Paris, France.
Geraldine Cancel-TassinCeRePP, Hopital Tenon, Paris, France.
Graham GilesCancer Epidemiology Centre, Cancer Council Victoria, University of Melbourne, Melbourne, Australia.
Robert MacInnisCancer Epidemiology Centre, Cancer Council Victoria, University of Melbourne, Melbourne, Australia.
Christiane MaierDepartment of Urology, University of Ulm, Ulm, Germany.
Alice S WhittemoreDepartment of Health Research and Policy, Stanford University, Stanford, California, United States of America.
Chih-Lin HsiehDepartment of Urology, University of Southern California, Los Angeles, California, United States of America.
Fredrik WiklundDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
William J CatalonaFeinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.
William FoulkesDepartment of Oncology and Human Genetics, Montreal General Hospital, Montreal, QC, Canada.
Diptasri MandalDepartment of Genetics, LSU Health Sciences Center, New Orleans, Louisiana, United States of America.
Rosalind EelesGenetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey, United Kingdom.
Zsofia Kote-JaraiGenetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey, United Kingdom.
Michael J AckermanDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
Timothy M OlsonDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
Christopher J KleinDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, United States of America.
Stephen N ThibodeauDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America.
Daniel J SchaidDivision of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.

Funding

Prostate Cancer Susceptibility: The ICPCG StudyU01CA089600 · NCI · MAYO CLINIC ROCHESTER · PI THIBODEAU, STEPHEN NORMAN · 2002 to 2016
$27.3M
Finding Genes for Human Prostate CancerZIAHG200325 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI OSTRANDER, ELAINE · 2009 to 2021
$17.7M
Genetic Epidemiology of CancerZIAHG200331 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI BAILEY-WILSON, JOAN ELLEN · 2009 to 2022
$11.7M
Quantitative Methods for Genetic EpidemiologyR01GM065450 · NIGMS · MAYO CLINIC ROCHESTER · PI SCHAID, DANIEL J. · 2002 to 2020
$5.6M
Cancer Research UK 15007Cancer Research UK 17528NCI NIH HHS U01 CA089600NIGMS NIH HHS R01 GM065450
6 · The paper itself

Abstract

Rare variants (RVs) have been shown to be significant contributors to complex disease risk. By definition, these variants have very low minor allele frequencies and traditional single-marker methods for statistical analysis are underpowered for typical sequencing study sample sizes. Multimarker burden-type approaches attempt to identify aggregation of RVs across case-control status by analyzing relatively small partitions of the genome, such as genes. However, it is generally the case that the aggregative measure would be a mixture of causal and neutral variants, and these omnibus tests do not directly provide any indication of which RVs may be driving a given association. Recently, Bayesian variable selection approaches have been proposed to identify RV associations from a large set of RVs under consideration. Although these approaches have been shown to be powerful at detecting associations at the RV level, there are often computational limitations on the total quantity of RVs under consideration and compromises are necessary for large-scale application. Here, we propose a computationally efficient alternative formulation of this method using a probit regression approach specifically capable of simultaneously analyzing hundreds to thousands of RVs. We evaluate our approach to detect causal variation on simulated data and examine sensitivity and specificity in instances of high RV dimensionality as well as apply it to pathway-level RV analysis results from a prostate cancer (PC) risk case-control sequencing study. Finally, we discuss potential extensions and future directions of this work.

Indexed as

Models, GeneticBayes TheoremCase-Control StudiesGenetic VariationHigh-Throughput Nucleotide SequencingHumansSequence Analysis, DNAburden testingMCMCNext-generation sequencingprostate cancer

Identifiers

PMID27312771
PMCPMC5063501

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.